Kalaris Therapeutics, Inc. ($KLRS)
Hagen Brett R โ Chief Accounting Officer
Shares
60,800
Price
$0.00
Total Value
$0.00
Nearby Earnings
Mar 6, 2026
EPS:Est: -0.56
Mar 13, 2026
EPS:-0.53 (est: -0.59)-9.6%
Mar 17, 2026
EPS:-0.44 (est: -0.59)-24.9%
Mar 20, 2026
EPS:Est: -0.59
Transaction Details
| Insider | Hagen Brett R |
|---|---|
| Title | Chief Accounting Officer |
| Transaction Date | Mar 19, 2026 |
| Expiration Date | Mar 18, 2036 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Stock Option (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Mar 23, 2026 |
| Shares Purchased | 60,800 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 60,800 |
| Derivative | Derivative |
| Accession Number | 0001193125-26-119707 |
| Document | View SEC Filing |